These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38159679)

  • 21. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
    Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study.
    Anderson AH; Yang W; Townsend RR; Pan Q; Chertow GM; Kusek JW; Charleston J; He J; Kallem R; Lash JP; Miller ER; Rahman M; Steigerwalt S; Weir M; Wright JT; Feldman HI;
    Ann Intern Med; 2015 Feb; 162(4):258-65. PubMed ID: 25686166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events.
    Buckley LF; Baker WL; Van Tassell BW; Cohen JB; Alkhezi O; Bress AP; Dixon DL
    Hypertension; 2023 Feb; 80(2):305-313. PubMed ID: 36254738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database.
    Gluck CA; Forrest CB; Davies AG; Maltenfort M; Mcdonald JR; Mitsnefes M; Dharnidharka VR; Dixon BP; Flynn JT; Somers MJ; Smoyer WE; Neu A; Hovinga CA; Skversky AL; Eissing T; Kaiser A; Breitenstein S; Furth SL; Denburg MR
    Clin J Am Soc Nephrol; 2023 Feb; 18(2):173-182. PubMed ID: 36754006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambulatory blood pressure variability and risk of cardiovascular events, all-cause mortality, and progression of kidney disease.
    Jhee JH; Seo J; Lee CJ; Park JT; Han SH; Kang SW; Park S; Yoo TH
    J Hypertens; 2020 Sep; 38(9):1712-1721. PubMed ID: 32516289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of achieved systolic blood pressure on renal function in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):271-276. PubMed ID: 29474712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
    Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
    Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term Blood Pressure Variability and Incident CKD in Patients With Hypertension: Findings From the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (CMERC-HI) Study.
    Jhee JH; Oh D; Seo J; Lee CJ; Chung MY; Park JT; Han SH; Kang SW; Park S; Yoo TH
    Am J Kidney Dis; 2023 Apr; 81(4):384-393.e1. PubMed ID: 36241008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-Term Systolic Blood Pressure Variability and Kidney Disease Progression in Patients With Chronic Kidney Disease: Results From C-STRIDE.
    Wang Q; Wang Y; Wang J; Zhang L; Zhao MH;
    J Am Heart Assoc; 2020 Jun; 9(12):e015359. PubMed ID: 32508195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systolic blood pressure, low-density lipoprotein cholesterol levels, and adverse kidney outcome: results from KNOW-CKD.
    Kim KW; Koh HB; Kim HW; Park JT; Yoo TH; Kang SW; Oh KH; Hyun YY; Jung JY; Sung SA; Kim J; Han SH
    Hypertens Res; 2023 Jun; 46(6):1395-1406. PubMed ID: 36849581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieved clinic blood pressure level and chronic kidney disease progression in children: a report from the Chronic Kidney Disease in Children cohort.
    Flynn JT; Carroll MK; Ng DK; Furth SL; Warady BA
    Pediatr Nephrol; 2021 Jun; 36(6):1551-1559. PubMed ID: 33200315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in glomerular filtration rate over time in the Oxford Renal Cohort Study: observational study.
    Hirst JA; Taal MW; Fraser SD; Mena JMO; O'Callaghan CA; McManus RJ; Taylor CJ; Yang Y; Ogburn E; Hobbs FR
    Br J Gen Pract; 2022 Apr; 72(717):e261-e268. PubMed ID: 34990394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
    Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of blood pressure with cardiovascular outcome and mortality: results from the KNOW-CKD study.
    Lee JY; Park JT; Joo YS; Lee C; Yun HR; Chang TI; Kim YH; Chung W; Yoo TH; Kang SW; Park SK; Chae DW; Oh KH; Han SH
    Nephrol Dial Transplant; 2022 Aug; 37(9):1722-1730. PubMed ID: 34473286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Anderson AH; Xie D; Wang X; Baudier RL; Orlandi P; Appel LJ; Dember LM; He J; Kusek JW; Lash JP; Navaneethan SD; Ojo A; Rahman M; Roy J; Scialla JJ; Sondheimer JH; Steigerwalt SP; Wilson FP; Wolf M; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):56-73.e1. PubMed ID: 32866540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients.
    Pan W; Han Y; Hu H; He Y
    BMC Nephrol; 2022 Aug; 23(1):295. PubMed ID: 35999502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort.
    Chiang HP; Lee JJ; Chiu YW; Tsai JC; Hung CC; Hwang SJ; Chen HC
    Am J Hypertens; 2014 Nov; 27(11):1396-407. PubMed ID: 24727359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.